EGFR and neoplasm: Notably, the model-estimated kkill for MIA PaCa-2 tumours was two-fold higher than that of PANC-1, consistent with the observation that CTX-MMAE was more efficacious in the MIA PaCa-2 xenograft tumour, despite the higher EGFR density on PANC-1.